A substantial conformational change upon cleavage of the protein chain certainly is understandable, if unusual, since the two structures do not have the same primary chemical bonds.
As introduced on the previous page, however, the serpins offer a third possibility - a latent state.
The stable latent form closely resembles the cleaved conformation, save that the loop that inserts between several b-strands is not cleaved.
| Human Antitrypsin (1ez2), Stable Conformation |
|---|
![]() |
This answers the question of where the energy comes from to drive the rearrangement.
Thrombin is a serine protease involved in blood clotting. It has a serpin inhibitor just like antitrypsin:
| Active Antithrombin (2ant) | Latent Antithrombin (2ant) |
|---|---|
![]() |
![]() |
Again the core of the structure remains largely unchanged; the rmsd 1.19 A:
| Alignment of Active and Latent Antithrombin |
|---|
![]() |
The change is initiated by binding of heparin or other oligosaccharides to the protein.
An exception to this behavior is ovalbumin, which does not form a latent state, nor, when cleaved, does it insert the cleaved loop among the b-strands.
| Ovalbumin |
|---|
![]() |
Despite the difference in behavior, much structural similarity exists between ovalbumin and the other serpins. Here, for example, is a superposition with native antitrypsin:
| Superposition of Antitrypsin and Ovalbumin |
|---|
![]() |
The rms is 1.13 A. Much sequence similarity (30% identity, 52% similarity) also exists, as shown in the alignment below (from BioEdit):
| Sequence Alignment of Antitrypsin and Ovalbumin |
|---|
![]() |
Convergent or divergent evolution?